Evidence map›Paper›PMID 41603224›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Competition Between Liquid-Liquid Crystalline Phase Separation (LLCPS) and Liquid-Liquid Phase Separation (LLPS) in Amyloid Fibril Colloidal Systems.

Milad Radiom, Raffaele Mezzenga

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Milad RadiomDepartment of Health Sciences and Technology, ETH Zürich, Zürich, 8092, Switzerland.ORCID https://orcid.org/0000-0002-6339-9288
Raffaele MezzengaDepartment of Health Sciences and Technology, ETH Zürich, Zürich, 8092, Switzerland.ORCID https://orcid.org/0000-0002-5739-2610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid fibrils are rigid, elongated protein aggregates that form condensed phases in functional biological assemblies and pathological deposits. From a colloidal physics perspective, two separation pathways can lead to these condensed phases: liquid-liquid phase separation (LLPS), which results from a trade-off between entropy and enthalpy, and liquid-liquid crystalline phase separation (LLCPS), an essentially entropic process in which the condensed phase is a nematic liquid following precise symmetry rules. The interplay between these pathways in amyloid fibril dispersions is debated. Here we show that lysozyme and β-lactoglobulin amyloid fibrils dominantly undergo LLCPS but exhibit a pH-dependent transition to LLPS. Particularly, increasing pH lowers the critical concentration for formation of nematic condensates until, near isoelectric point, where condensates without a coherent nematic order form. This behavior is consistent with the classical picture of rigid rods retaining nematic order once formed, with enthalpic attraction overcoming entropic ordering at low charge densities. Our work establishes that LLCPS and LLPS in amyloid fibrils are separable and provides a framework for controlling fibril organization using simple solution conditions. The competition between LLCPS and LLPS may clarify the mesoscopic organization of amyloid fibrils in condensates in vivo and direct design principles of multiphase amyloid-based materials.

Indexed as

AmyloidLiquid CrystalsAnimalsColloidsHydrogen-Ion ConcentrationLactoglobulinsMuramidasePhase SeparationAmyloidColloidsLactoglobulinsMuramidaseamyloid fibrilscondensatesliquid crystalsLLCPSLLPSphase diagramphase transition

Identifiers

PMID41603224
PMCPMC13045426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.